Altrenogest

Spécifications

850-52-2Numéro CAS

212-703-1Numéro CE

(8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-oneNom IUPAC

C21H26O2Formule chimique

310.4 g/molMasse molaire

Altrenogest; 850-52-2; Allyltrenbolone; Allyl trenbolone; Altrenogestum; RU-2267; REGU-MATE; DTXSID3048863; A-35957; 2U0X0JA2NB; NSC-759180; 17-alpha-Allyl-estratriene-4,9,11,17-beta-ol-3-one; DTXCID6028789; Estra-4,9,11-trien-3-one, 17beta-hydroxy-17-(2-propenyl)-; Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propen-1-yl)-, (17beta)-; Altrenoges; Altren; ChronoMate; SwineMate; OvaMed; 17-allyltrenbolone; RefChem:54135; 17 alpha-allyl-estratriene 4,9,11,17 beta-ol-one; 17 alpha-allyl-17-beta-hydroxyestra-4,9,11-trien-3-one; (17 beta)-17-hydroxy-17-(2-propenyl)estra-4,9,11-trien-3-one; (1R,3aS,3bS,11aS)-1-hydroxy-11a-methyl-1-(prop-2-en-1-yl)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-cyclopenta(a)phenanthren-7-one; 212-703-1; Matrix; Regumate; 17alpha-Allyl-17-hydroxyestra-4,9,11-trien-3-one; (8S,13S,14S,17R)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one; MFCD00867855; (8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (17beta)-17-Hydroxy-17-(2-propenyl)estra-4,9,11-trien-3-one; CAS-850-52-2; Allyltrenbolone;RU2267; DRC 6246; UNII-2U0X0JA2NB; Altrenogestum [INN-Latin]; RU 2267; Altrenogest [USAN:INN:BAN]; R 2267; NCGC00183119-01; A 35957; DRC-6246; EINECS 212-703-1; ALTRENOGEST [MI]; ALTRENOGEST [INN]; Altrenogest (USAN/INN); ALTRENOGEST [USAN]; ALTRENOGEST [MART.]; SCHEMBL140056; orb1310215; orb3139272; ALTRENOGEST [GREEN BOOK]; CHEMBL1315492; MSK2281; CHEBI:191255; VWAUPFMBXBWEQY-ANULTFPQSA-N; HMS3715D18; HY-B0521; Tox21_113356; MSK2281-100M; s3167; AKOS025310098; Estra-4,9,11-trien-3-one, 17-hydroxy-17-(2-propenyl)-, (17-beta)-; MSK2281-1000M; Tox21_113356_1; CCG-221218; DB11372; FA17333; NSC 759180; RH-2267; NCGC00166309-01; NCGC00166309-02; AS-12848; SY053182; Altrenogest 100 microg/mL in Acetonitrile; A2892; A4679; Altrenogest Solution in Methanol, 100ug/mL; NS00014198; Altrenogest Solution in Methanol, 1000ug/mL; D02840; AB01566827_01; Altrenogest, VETRANAL(TM), analytical standard; F462716; 17a-Allyl-17-hy droxyestra-4,9,11-trien-3-one; Q4736979; 11-trien-3-one,17-alpha-allyl-17-hydroxy-estra-9; 17-alpha-Allyl-17-beta-hydroxyestra-4,9,11-trien-3-one; (17b)-17-Hydroxy-17-(2-propenyl)estra-4,9,11-trien-3-one; ESTRA-4,9,11-TRIEN-3-ONE, 17-alpha-ALLYL-17-HYDROXY-; (17b)-17-Hydroxy-17-(2-propen-1-yl)estra-4,9,11-trien-3-one; 17.ALPHA.-ALLYL-ESTRA-4,9,11-TRIENE-17.BETA.-OL-3-ONE; ESTRA-4,9,11-TRIEN-3-ONE, 17.BETA.-HYDROXY-17-(2-PROPENYL)-; ESTRA-4,9,11-TRIEN-3-ONE, 17-HYDROXY-17-(2-PROPEN-1-YL)-, (17.BETA.)-; (1R,3aS,3bS,11aS)-1-Hydroxy-11a-methyl-1-(prop-2-en-1-yl)-1,2,3,3a,3b,4,5,8,9,11a-decahydro-7H-cyclopenta[a]phenanthren-7-one; (8S,13R,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one; (8S,13S,14S,17R)-17-allyl-17-hydroxy-13-methyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-oneSynonymes